Aimed Bio Inc. (KOSDAQ:0009K0)

South Korea flag South Korea · Delayed Price · Currency is KRW
48,850
-2,050 (-4.03%)
At close: Apr 28, 2026
Market Cap 3.16T
Revenue (ttm) 47.28B
Net Income (ttm) 5.02B
Shares Out 64.67M
EPS (ttm) 101.00
PE Ratio 629.00
Forward PE 287.35
Dividend n/a
Ex-Dividend Date n/a
Volume 185,568
Average Volume 201,780
Open 50,000
Previous Close 50,900
Day's Range 48,800 - 50,000
52-Week Range 42,000 - 80,200
Beta n/a
RSI 46.83
Earnings Date Apr 13, 2026

About Aimed Bio

Aimed Bio Inc. develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases. Its multidisciplinary platform offers antibody-drug conjugates, blood-brain barrier penetration, brain immune modulation, and patient-derived models (PDC/PDX). Aimed Bio Inc. was founded in 2018 and is based in Seoul, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2018
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 0009K0
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.